HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$18.18
Day range
$18.19 - $19.12
Year range
$5.12 - $20.29
Market cap
1.64B USD
Avg Volume
1.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 62.90M | 69.56% |
Operating expense | 65.62M | -3.22% |
Net income | -54.81M | -136.36% |
Net profit margin | -87.14 | -121.44% |
Earnings per share | -0.46 | -120.26% |
EBITDA | -44.79M | 44.78% |
Effective tax rate | 0.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 277.44M | -56.28% |
Total assets | 504.41M | -39.44% |
Total liabilities | 534.86M | -3.29% |
Total equity | -30.45M | — |
Shares outstanding | 78.05M | — |
Price to book | -46.62 | — |
Return on assets | -26.54% | — |
Return on capital | -35.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -54.81M | -136.36% |
Cash from operations | -42.51M | 28.12% |
Cash from investing | 46.13M | -65.40% |
Cash from financing | 46.00K | 107.26% |
Net change in cash | 4.12M | -94.39% |
Free cash flow | -29.37M | 24.75% |
About
Founded
2008
Website
Employees
380
